Cetirizine vs Levocetirizine for Allergic Conditions

Clinical Efficacy Evidence

The American Academy of Allergy, Asthma, and Immunology recommends both medications as first-line treatments for allergic rhinitis, with oral H1-antihistamines representing the primary therapeutic approach 1
Levocetirizine decreased symptoms and improved quality of life in patients with persistent allergic rhinitis and asthma, with prolonged 6-month therapy reducing comorbidities including asthma, according to the European Academy of Allergy and Clinical Immunology 2, 1
Cetirizine relieves both upper and lower respiratory tract symptoms in patients with allergic rhinitis and concomitant asthma, as stated by the American College of Allergy, Asthma, and Immunology 1

Cetirizine causes mild drowsiness in approximately 13.7% of patients compared to 6.3% with placebo, which is a clinically meaningful sedation risk even at standard 10 mg doses, as reported by the National Institute for Health and Care Excellence 3, 4
Both medications have negligible hepatic metabolism and are primarily excreted unchanged in urine, minimizing drug interaction potential, according to the FDA 3, 4
Both are FDA Pregnancy Category B drugs with no evidence of fetal harm, though ideally all antihistamines should be avoided in pregnancy, especially first trimester, as recommended by the American College of Obstetricians and Gynecologists 3, 4

Cetirizine dose must be halved in moderate renal impairment (CrCl 10-20 mL/min) and avoided in severe renal impairment (CrCl <10 mL/min), as advised by the National Kidney Foundation 3, 4

Patients should be counseled about driving and machinery operation due to the sedation risk associated with cetirizine, which carries a 13.7% sedation risk at standard doses, as warned by the Centers for Disease Control and Prevention 3, 4
Standard dosing in renal impairment without adjustment should be avoided—both medications require dose reduction or avoidance in kidney disease, as emphasized by the European Renal Association 3, 4
Patients with low body mass may experience elevated drug levels (mg/kg basis) with standard age-based dosing, potentially developing drowsiness, according to the World Health Organization 3

For patients with moderate renal impairment (CrCl 10-20 mL/min), the dose of both cetirizine and levocetirizine should be halved, according to the British Journal of Dermatology 5
In cases of severe renal impairment (CrCl <10 mL/min), both medications should be avoided entirely, as recommended by the British Journal of Dermatology 5

Both cetirizine and levocetirizine have excellent safety profiles in children ≥6 years, with second-generation antihistamines showing superior tolerability compared to first-generation agents, according to the Journal of Allergy and Clinical Immunology 6

The British Journal of Dermatology recommends avoiding both cetirizine and levocetirizine in pregnancy, especially in the first trimester, due to potential fetal harm 5
In children <6 years, all OTC cough/cold combination products should be avoided due to toxicity concerns, although second-generation antihistamines like cetirizine and levocetirizine have excellent safety profiles when used appropriately, as stated by the Journal of Allergy and Clinical Immunology 6